Project Grant HT94252410961
Award Date
11/1/24
Completion Date
10/31/26
Dollars Obligated
$145K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Oklahoma City, OK 73104, USA
Similar Awards
The University of Oklahoma Health Sciences Center was awarded an $864,781 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from April 1, 2023 to March 31, 2026 targeting DCLK1-driven chemoresistance in ovarian cancer. The goal aligns with the Military Medical Research and Development program's focus on innovative medical solutions for Service Members and the public through...
The University of Oklahoma (OU) was awarded a $1,051,250 Project Grant from the Defense Health Agency to conduct research on the re-expression of miR-195 as a therapeutic strategy for chemoresistant ovarian cancer. This research falls under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform health care for service members and the American public. The project is scheduled to run from August 15, 2023, to August 14, 2027. As a public...
The University of Oklahoma Health Sciences Center was awarded a $427,109 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) on May 15, 2025. The grant supports research to investigate "TARGETING DCLK1-MEDIATED GLUTAMINE ADDICTION IN CHEMORESISTANT OVARIAN CANCER METASTASES", with a performance period ending on May 14, 2027. The Military Medical Research and Development program funds a diverse portfolio of advanced biomedical...
This Project Grant award, valued at $541,837.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at the University of Oklahoma Health Sciences Center, with the aim of developing a drug-targeting ORP4 as a precision ovarian cancer treatment. The award period runs from May 1, 2025 to April 30, 2029, leveraging the university's expertise in medical research and product development...
This $1,144,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Oklahoma Health Sciences Center to develop a drug targeting ORP4 as a precision treatment for ovarian cancer. The research aims to transform healthcare for military service members, veterans, and the broader public through innovative investigations spanning basic, applied, and translational domains....
The U.S. Department of Defense's Defense Health Agency awarded Oklahoma State University a $1,234,405 Block Grant under the Military Medical Research and Development program (CFDA 12.420) on June 1, 2024. The grant supports a multi-year research partnership to develop innovative biomedical solutions relevant to military personnel and the broader public. Through this funding, Oklahoma State University will conduct a comprehensive range of investigative projects across disciplines such as cancer...
The University of Oklahoma's Health Sciences Center Division was awarded a $717,750 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate one-carbon metabolic alterations to target pancreatic cancer cachexia. The research effort aims to develop new treatments and improve patient care for this condition, which is a major concern for service members and veterans. The three-year project will be conducted in Oklahoma City,...
This $2,131,863 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at the University of Oklahoma Health Sciences Center to investigate expanded GAA-GGA chimeric repeats in Friedreich ataxia. The research aims to transform healthcare for military service members, veterans, and the public by addressing critical health challenges related to this genetic disorder. The 4-year...
The University of Oklahoma received a $2,273,306 federal Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "NEUROPEPTIDE MODULATION OF CEREBRAL BLOOD FLOW TO IMPROVE NEUROLOGICAL AND PSYCHOLOGICAL OUTCOMES FOLLOWING TBI IN THE PRESENCE AND ABSENCE OF TRAUMATIC STRESS". The 4-year grant, which began on Jul 1, 2023, aims to investigate medical solutions for traumatic brain injuries (TBI) and the impacts...
This Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development (CFDA 12.420) federal grant program, provides $688,500.00 in funding to the University of Arkansas for Medical Sciences (UAMS) for a 3-year period from November 15, 2024 to November 14, 2027. The grant supports research to investigate "Mechanisms of Combinatorial Therapy to Enhance Anti-PD-1 Immune Checkpoint Inhibition for Ovarian Cancer". As a leading academic...